SCHEMBL3067892

SCHEMBL3067892

C[C@H]1CN2c3c(cc(C#Cc4cc5ccccc5s4)c(F)c3F)CC3(C(=O)NC(=O)NC3=O)[C@@H]2[C@@H](C)O1

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3062583 0.88 TOP2A (0.43) TOP2A
SCHEMBL3068279 0.88 TOP2A (0.48) TOP2A
SCHEMBL3063003 0.86 TOP2A (0.55) TOP2A
SCHEMBL3069877 0.82 TOP2A (0.56) TOP2A
SCHEMBL3062127 0.81 TOP2A (0.51) TOP2A
SCHEMBL3062848 0.81 TOP2A (0.59) TOP2A
SCHEMBL3060335 0.81 TOP2A (0.63) TOP2A
SCHEMBL3065403 0.80 TOP2A (0.58) TOP2A
SCHEMBL12725611 0.80 TOP2A (0.63) TOP2A
SCHEMBL3052380 0.80 TOP2A (0.55) TOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100261719-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261719-A1 CHEMICAL COMPOUNDS NCOA3, NR4A3, NR0B2 TOP2A 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.